Entity

Time filter

Source Type

Cambridge, MA, United States

Trademark
Ares Trading S.A., Peptimmune Acquisition Llc and Peptimmune Inc. | Date: 2002-06-11

pharmaceutical compositions for the modulation of allergic, immune or autoimmune responses.


Trademark
Peptimmune Inc. | Date: 1997-03-27

peptide-based immune system response modifiers in prescription pharmaceutical compositions for the modulation of immune or autoimmune responses in the prophylaxis or treatment of conditions in the nature of insulin dependent, juvenile-onset diabetes, multiple sclerosis, pemphigus vulgaris, Graves disease, myasthenia gravis, systemic lupus erythematosus, rheumatoid arthritis, Hashimotos thyroiditis, asthma, pathogenic infections, cancer, and allogeneic tissue graft rejection.


Trademark
Peptimmune Inc. | Date: 2010-01-20

Pharmaceutical products for treatment of central nervous system disorders, antidotes, vaccines, and veterinary vaccines.


Trademark
Peptimmune Inc. | Date: 2003-10-10

Pharmaceutical compositions for the modulation of allergic, immune or autoimmune responses.


Trademark
Ares Trading S.A., Peptimmune Acquisition Llc and Peptimmune Inc. | Date: 2004-03-23

pharmaceutical compositions for the modulation of allergic, immune or autoimmune responses.

Discover hidden collaborations